Skip to content

The prospective study on the effects of different balloon size and different dilation time on pancreatitis after ERCP surgery

The prospective study on EST combining with EPBD and different time on pancreatitis after endoscopic retrograde cholangiopancreatography surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014259
Enrollment
Unknown
Registered
2018-01-02
Start date
2018-01-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic duct disease

Interventions

Duodenal nipple incision combined small balloon expansion 1 minute:Balloon expansion 1 minute
Duodenal nipple incision combined small balloon expansion3 minutes:Balloon expansion 3 minutes
Duodenal nipple incision combined large balloon expnsion1 minutes:Balloon expansion 1 minute
Duodenal nipple incision combined large balloon expnsion 3 minutes:Balloon expansion 3 minutes

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 85 years; clinically diagnosed with common bile duct stones (diameter 8–10 mm); 2. no severe cardiopulmonary or renal failure; 3. platelets >50x10^9/L; 4. PT prolongation less than 3 seconds; 5. no usage of anticoagulant or antiplatelet drugs or discontinuation of anticoagulant or antiplatelet drugs for more than 3 days.

Exclusion criteria

Exclusion criteria: 1. patients with pancreatitis; 2. patients for EST pre-cut; 3. patients with a history of EST or EPBD; 4. patients with a long and narrow bile duct, pancreaticobiliary duodenal papillary tumours or biliary cysts; 5. patients with a history of gastrointestinal reconstruction, such as Bismuth II gastrectomy, Roux-en-Y gastrectomy (biliary tube traversed), or pancreaticoduodenectomy; 6. patients with a history of unsuccessful cannulation; 7. patients who refused to participate; 8. pregnant or breastfeeding patients.

Design outcomes

Primary

MeasureTime frame
Postoperative pancreatitis;

Countries

China

Contacts

Public ContactYuanyuan Li

The First Affiliated Hospital of Nanchang University

easily008@163.com+86 15083522327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026